6-KThe Wire
Innate Pharma SA files 6-K
Filed Apr 23, 2026 · 2mo ago · Accession 0001628280-26-026676
Plain English
Innate Pharma S.A. announced its first quarter 2026 business update and cash position. The company reported a cash and cash equivalents balance of €154 million as of March 31, 2026.
Filing details
- Company
- Innate Pharma SA
- Ticker
- IPHA
- CIK
- 1598599
- Form type
- 6-K
- Filing date
- Apr 23, 2026
- Report date
- Apr 23, 2026
- Document
- a6k-iphx260423.htm
- Size
- 22 KB